CareSpan Health, Inc. (TSXV:CSPN)
Canada
· Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
May 16, 2025, 4:00 PM EDT
CareSpan Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 0.6 | 2.53 | 4.54 | 5.76 | 3.44 | Upgrade
|
| Revenue Growth (YoY) | -76.13% | -44.33% | -21.09% | 67.42% | 6846.45% | Upgrade
|
| Cost of Revenue | 1.17 | 3.59 | 6.57 | 7.5 | 4.68 | Upgrade
|
| Gross Profit | -0.56 | -1.06 | -2.03 | -1.74 | -1.24 | Upgrade
|
| Selling, General & Admin | 0.38 | 0.81 | 1.26 | 1.58 | 0.99 | Upgrade
|
| Operating Expenses | 0.25 | 0.85 | 1.58 | 1.99 | 1.99 | Upgrade
|
| Operating Income | -0.81 | -1.91 | -3.6 | -3.73 | -3.23 | Upgrade
|
| Interest Expense | -0.17 | -0.14 | - | -1.43 | -0.64 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | 0.43 | - | 0.04 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.02 | -0.03 | -1.99 | -1.73 | Upgrade
|
| EBT Excluding Unusual Items | -1.12 | -1.64 | -3.63 | -7.11 | -5.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.04 | - | -1.05 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.73 | - | 1.4 | - | - | Upgrade
|
| Asset Writedown | -0.19 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 0.04 | 0.14 | 0.25 | -0.31 | Upgrade
|
| Pretax Income | -0.54 | -1.6 | -3.14 | -6.86 | -5.95 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.04 | Upgrade
|
| Earnings From Continuing Operations | -0.54 | -1.6 | -3.14 | -6.86 | -5.91 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.25 | 0.33 | 0.12 | Upgrade
|
| Net Income | -0.54 | -1.6 | -2.89 | -6.53 | -5.79 | Upgrade
|
| Net Income to Common | -0.54 | -1.6 | -2.89 | -6.53 | -5.79 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 47 | 31 | 8 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 47 | 31 | 8 | 5 | Upgrade
|
| Shares Change (YoY) | 1.92% | 52.05% | 273.12% | 77.78% | -76.09% | Upgrade
|
| EPS (Basic) | -0.01 | -0.03 | -0.09 | -0.79 | -1.25 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.03 | -0.09 | -0.79 | -1.25 | Upgrade
|
| Free Cash Flow | -0.91 | -1.64 | -2.26 | -2.97 | -1.71 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.07 | -0.36 | -0.37 | Upgrade
|
| Gross Margin | -93.14% | -41.87% | -44.63% | -30.29% | -36.06% | Upgrade
|
| Operating Margin | -134.31% | -75.43% | -79.32% | -64.81% | -93.96% | Upgrade
|
| Profit Margin | -89.92% | -63.42% | -63.63% | -113.46% | -168.25% | Upgrade
|
| Free Cash Flow Margin | -151.41% | -64.89% | -49.77% | -51.63% | -49.63% | Upgrade
|
| EBITDA | - | -1.9 | -3.59 | -3.73 | -3.23 | Upgrade
|
| EBITDA Margin | - | -74.95% | -79.05% | -64.74% | -93.91% | Upgrade
|
| D&A For EBITDA | - | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| EBIT | -0.81 | -1.91 | -3.6 | -3.73 | -3.23 | Upgrade
|
| EBIT Margin | -134.31% | -75.43% | -79.32% | -64.81% | -93.96% | Upgrade
|
| Revenue as Reported | 0.6 | 2.53 | 4.54 | 5.76 | 3.44 | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.